ATE255577T1 - Gemischte paroxetin-propan-2-olsolvate - Google Patents

Gemischte paroxetin-propan-2-olsolvate

Info

Publication number
ATE255577T1
ATE255577T1 AT99973027T AT99973027T ATE255577T1 AT E255577 T1 ATE255577 T1 AT E255577T1 AT 99973027 T AT99973027 T AT 99973027T AT 99973027 T AT99973027 T AT 99973027T AT E255577 T1 ATE255577 T1 AT E255577T1
Authority
AT
Austria
Prior art keywords
solvate
mixed
paroxetine
propane
propan
Prior art date
Application number
AT99973027T
Other languages
English (en)
Inventor
Andrew Simon Craig
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9826182.9A external-priority patent/GB9826182D0/en
Priority claimed from GBGB9916257.0A external-priority patent/GB9916257D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE255577T1 publication Critical patent/ATE255577T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT99973027T 1998-11-30 1999-11-30 Gemischte paroxetin-propan-2-olsolvate ATE255577T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9826182.9A GB9826182D0 (en) 1998-11-30 1998-11-30 Novel process
GBGB9916257.0A GB9916257D0 (en) 1999-07-12 1999-07-12 Novel compounds
PCT/GB1999/003993 WO2000032594A1 (en) 1998-11-30 1999-11-30 Mixed paroxetine propan-2-ol solvates

Publications (1)

Publication Number Publication Date
ATE255577T1 true ATE255577T1 (de) 2003-12-15

Family

ID=26314751

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99973027T ATE255577T1 (de) 1998-11-30 1999-11-30 Gemischte paroxetin-propan-2-olsolvate

Country Status (9)

Country Link
EP (2) EP1408039A3 (de)
JP (1) JP2002531452A (de)
AT (1) ATE255577T1 (de)
AU (1) AU1397900A (de)
DE (1) DE69913377T2 (de)
DK (1) DK1135383T3 (de)
ES (1) ES2211232T3 (de)
PT (1) PT1135383E (de)
WO (1) WO2000032594A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1017421C2 (nl) 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
WO2007054978A2 (en) * 2005-11-10 2007-05-18 Jubilant Organosys Limited Process for preparing paroxetine hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
EP1394160A1 (de) * 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Verfahren zur Herstellung von kristallinem Paroxetin-Hydrochlorid
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására

Also Published As

Publication number Publication date
PT1135383E (pt) 2004-04-30
EP1408039A3 (de) 2004-05-12
ES2211232T3 (es) 2004-07-01
WO2000032594A1 (en) 2000-06-08
EP1135383B1 (de) 2003-12-03
DE69913377D1 (de) 2004-01-15
EP1135383A1 (de) 2001-09-26
AU1397900A (en) 2000-06-19
EP1408039A2 (de) 2004-04-14
JP2002531452A (ja) 2002-09-24
DK1135383T3 (da) 2004-04-05
DE69913377T2 (de) 2004-12-30

Similar Documents

Publication Publication Date Title
DK0532515T3 (da) Fremstilling af substituerede piperidiner
WO2003025729A1 (en) Gui part focus movement destination setter and focus moving device
FI964520L (fi) Atsabisykloyhdisteet
ATE456564T1 (de) Octahydrobenzimidazolon-verbindungen als analgetika
BR9206823A (pt) Preparação de piperidinas substituídas
ATE255577T1 (de) Gemischte paroxetin-propan-2-olsolvate
DK0565558T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af azabicyclo(2.2.2)octan-3-iminer
PT102343B (pt) Processo para a preparacao de furoato mometasona
ATE255103T1 (de) Verfahren zur herstellung von pyridinmethanol- verbindungen
DK1251123T3 (da) Fremgangsmåde til fremstilling af quinolylacrylonitril og mellemprodukter derfor
DE60232006D1 (de) Rückgewinnung und recycling chiraler weinsäureverbindungen zur racematspaltung
DK0711764T3 (da) Fremgangsmåde til fremstilling af L-ascorbinsyre
ATE250065T1 (de) Verfahren zur demethoxycarbonylisierung von porphirinicverbindungen, wie pheophorbiderivate
DK1219625T3 (da) Hidtil ukendte substituerede 2-(6-benzyl-5-oxo-3-phenyl-(S3,7S,7AR)-perhydroimidazol-(1,5-C)(1,3) thiazol-7YL)forbindelser
ES8203015A1 (es) Procedimiento para preparar un solvato de amoxicilina sodicacon n-metil-2-metil-pirrolidona
DK1021431T3 (da) Fremgangsmåde til fremstilling af eventuelt substituerede benzofuranoner
DE69004320D1 (de) Hydroxyphenethylamin-Derivat und dessen Salze, Verfahren zur Herstellung, medizinische Verwendung und Verwendung als spezifisches pharmakologisches Werkzeug.
SE7704870L (sv) Forfarande for framstellning av 4-substituerade imidazolforeningar
EA200200776A1 (ru) Этанольный сольват (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она
DK0406065T3 (da) Fremgangsmåde til fremstilling af pseudo-ionon
DK463281A (da) Cyclopropanderivater
ATE242947T1 (de) Authentifikation eines abonnenten eines telekommunikationsdienstes mittels einer häufig gewählten zieladresse
KR960008634B1 (en) Cyclo propane derivatives and its preparation
DE59002172D1 (de) Neue 1,3-oxazine.
DK1202948T3 (da) Fremgangsmåder til fremstilling af 2-arylvinylalkylethere og 1,4-aryl-2-fluor-2-butenforbindelser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1135383

Country of ref document: EP